Jay Barth

Company: Lexeo Therapeutics

Job title: Executive Vice President & Chief, Medical Officer

Seminars:

Discovering Gene therapy for APOE4-Associated Alzheimer’s Disease 11:00 am

Reviewing the role of APOE in the pathogenesis of Alzheimer’s Disease Understanding the approach of AAV-based gene therapy to treat Alzheimer’s Disease patients who are APOE homozygous Describing the Phase 1 study design of LX1001Read more

day: Track B - Day 2